IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC includes a print copy delivered by postal mail and on-line access to electronic PDF copies of your subscribed issues.

Stability Issues for Compounding Extemporaneously Prepared Oral Formulations for Pediatric Patients

Author(s):  Schotik Debora

Issue:  Jan/Feb 2001 - Compounding for Pediatric Patients
View All Articles in Issue

Abstract:  More than 80% of prescription drugs approved by the US Food and Drug Administration for human use are not approved for use in the pediatric population. When there is not a commercially available dosage form for pediatric use, it is the pharmacist’s responsibility to compound a stable and acceptable formula in accordance with good pharmacy practices, official standards and relevant scientific data. The author discusses the stability of formulations; factors affecting stability; types of oral liquids; beyond-use dating; flavors, taste and coloring; issues for administration of medications to children and stability studies (information sources, the pharmacist and the literature and US Food and Drug Administration updates).

Related Keywords: beyond-use date, children, coloring, emulsions, flavors, infants, oral formulations, oral liquids, pediatric, pediatric administration, solutions, stability, suspensions, taste, Loyd V. Allen, Jr., PhD, RPh, continuing education, quality control, endotoxins, pyrogens, gram-negative bacteria, lipopolysaccharide, endotoxin limit, endotoxin load, sterile preparations, standards, USP

Related Categories: PEDIATRICS, STABILITIES, COMPATIBILITIES, UNITED STATES PHARMACOPEIA CONVENTIONS

Printer-Friendly Version




Download in electronic PDF format for $35

Related Articles from IJPC
Title (Click for Abstract / Details) Author Issue Page View/Buy
Stability Issues for Compounding Extemporaneously Prepared Oral Formulations for Pediatric Patients Schotik Debora Jan/Feb 2001 9-12 Buy
Pediatric Compounding: Coloring Outside the Lines Preckshot John Jan/Feb 2001 6-8 Buy
Rapid-Dissolve Technology: An Interview With Loyd V. Allen, Jr., PhD, RPh Allen Loyd V Jr Nov/Dec 2003 449-450 Buy
Pediatric Dermatitis Remmert Renee Nov/Dec 2002 419-421 Buy
Featured Excipient: Flavor Enhancing Agents Allen Loyd V Jr Jan/Feb 2003 48-50 Buy
Extended Stability of Morphine and Sildenafil for Oral Use in Infants and Young Children Nahata Milap C May/Jun 2016 247-249 Buy
Basics of Compounding for Pediatric Patients: Commonly Prescribed Oral Liquid Formulations, Vehicles, and Stock Solutions Fonseca Simonne C Nov/Dec 2005 456-461 Buy
Need for Appropriate Formulations for Children: The National Institute of Child Health and Human Development--Pediatric Formulations Initiative, Part 2 Giacoia George P, Taylor-Zapata Perdita, Mattison Donald May/Jun 2007 220-225 Buy
Quality-Control Analytical Methods: Endotoxins: Essential Testing for Pyrogens in the Compounding Laboratory, Part 3: A Simplified Endotoxin Test Method for Compounded Sterile Preparations Cooper James F Jan/Feb 2011 49-54 Buy
The Basics of Compounding Emulsions, Part 2 Allen Loyd V Jr May/Jun 2001 198-201 Buy